My Secret PsA Playbook with Dr.Jonathan Chan

🎙️🎙️🎙️ 𝐂𝐫𝐨𝐬𝐬𝐢𝐧𝐠 𝐨𝐯𝐞𝐫 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐬𝐤𝐢𝐧 𝐭𝐨 𝐭𝐡𝐞 𝐣𝐨𝐢𝐧𝐭𝐬 𝐚𝐧𝐝 𝐞𝐯𝐞𝐫𝐲𝐭𝐡𝐢𝐧𝐠 𝐢𝐧 𝐛𝐞𝐭𝐰𝐞𝐞𝐧, 𝐰𝐞 𝐜𝐡𝐚𝐭 𝐰𝐢𝐭𝐡 𝐕𝐚𝐧𝐜𝐨𝐮𝐯𝐞𝐫-𝐛𝐚𝐬𝐞𝐝 𝐫𝐡𝐞𝐮𝐦𝐚𝐭𝐨𝐥𝐨𝐠𝐢𝐬𝐭, 𝐃𝐫.𝐉𝐨𝐧𝐚𝐭𝐡𝐚𝐧 𝐂𝐡𝐚𝐧, who 𝐭𝐚𝐤𝐞𝐬 𝐮𝐬 𝐨𝐧 𝐚 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐬𝐞𝐜𝐫𝐞𝐭𝐬 𝐌𝐚𝐬𝐭𝐞𝐫𝐂𝐥𝐚𝐬𝐬.

🔑🔑💡 𝐓𝐍𝐅, 𝐈𝐋, 𝐉𝐀𝐊 -𝐰𝐡𝐚𝐭 and how 𝐝𝐨 I 𝐜𝐡𝐨𝐨𝐬𝐞 therapy for PsA?

🎧🎧 It's  a candid conversation where Dr.Chan reveals his psoriatic arthritis PsA clinical secrets ie. the PsA clinical playbook.

We also explore the world of biosimilars, and a one-of-a kind collaborative clinic with Skin and Joints Faculty, Dr.Jan Dutz.

😉 𝐘𝐨𝐮 𝐨𝐧𝐥𝐲 𝐥𝐞𝐚𝐫𝐧 𝐭𝐡𝐢𝐬 𝐬𝐭𝐮𝐟𝐟 𝐢𝐟 𝐲𝐨𝐮 𝐰𝐨𝐫𝐤 𝐚𝐥𝐨𝐧𝐠𝐬𝐢𝐝𝐞 𝐃𝐫.Chan, 𝐨𝐫, of course, 𝐢𝐟 𝐲𝐨𝐮 𝐥𝐢𝐬𝐭𝐞𝐧 𝐭𝐨 𝐭𝐡𝐞 Skin and Joints Podcast.

Email us: info@skinandjoints.ca

 

About Dr.Jonathan Chan, MD, FRCPC  

Rheumatologist  | Vancouver

 Dr. Chan is an assistant clinical professor at the University of British Columbia and an Adult Rheumatologist and Clinical Investigator with Arthritis Research Canada. (ARC). He has a clinical focus and research interest in the areas of axial spondyloarthritis and psoriatic arthritis. He was awarded an Assessment of Spondyloarthritis Society (ASAS) fellowship grant and completed a clinical fellowship at the University of Toronto in axial spondyloarthritis (ankylosing spondylitis).  Dr.Chan actively pursues research in this field and has been invited to present on this topic internationally in addition to being the coauthor of the Canadian Spondylitis Treatment Guidelines.

His research focuses on early identification, long term outcomes, radiographic progression, and use of administrative databases. Dr.Chan is the core site leader of the  national spondylitis and psoriatic arthritis research cohorts (SPARCC and iPART)  which follow patients with spondyloarthritis and psoriatic arthritis. He also participates in clinical trials evaluating the efficacy and safety of mew therapies in these types of inflammatory arthritis.

 

Learning Objectives 

• Discuss appropriate  strategies for managing  patients with moderate to severe psoriatic arthritis  (PsA)
• Describe real world clinical  implications and therapy considerations for managing  moderate to severe psoriatic arthritis  (PsA)
• Implement strategies to improve multidisciplinary care coordination between primary care providers and specialty care providers and address the needs of patients with PsA.

*Episode recorded earlier.

Supported by IME grants from TEVA and Bristol Myers Squibb.
www.skinandjoints.ca

📻www.skinandjoints.ca

✉️info@skinandjoints.ca